Open | $15.200 |
Close | $14.680 |
Volume / Avg. | 759.157K / 525.151K |
Day Range | 14.200 - 15.200 |
52 Wk Range | 4.270 - 16.650 |
Market Cap | $989.077M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 10.55% |
Days to Cover | 15.77 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ORIC Pharmaceuticals (NASDAQ: ORIC) through any online brokerage.
Other companies in ORIC Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Zentalis Pharma (NASDAQ:ZNTL), Centessa Pharmaceuticals (NASDAQ:CNTA) and Sage Therapeutics (NASDAQ:SAGE).
The latest price target for ORIC Pharmaceuticals (NASDAQ: ORIC) was reported by Oppenheimer on Tuesday, March 12, 2024. The analyst firm set a price target for 17.00 expecting ORIC to rise to within 12 months (a possible 15.80% upside). 17 analyst firms have reported ratings in the last year.
The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $14.68 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for ORIC Pharmaceuticals.
ORIC Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for ORIC Pharmaceuticals.
ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.